- Joined
- Dec 5, 2013
- Messages
- 4
A new study published in the American Journal of Clinical Nutrition suggests that dietary dehydroascorbic acid, the oxidized form of vitamin C, might be useful for some Crohn's patients. Researchers at the University of Manitoba, Canada, studied the gene that codes for the transporter of the common form of vitamin C called ascorbic acid and found that a specific polymorphism was more prevalent in Crohn's patients than in controls. "If, as we hypothesize, intracellular ascorbate concentrations of specific intestinal cell types will decrease by the action of SNPs in SLC23A1, a supplementation with dehydroascorbate would be worthy of study as the therapy of choice to compensate for this shortfall...supplemented externally, dehydroascorbate enters the cell through facilitated glucose transporter of the GLUT family, not SLC23A1...the proposed gene-specific personalized nutritional therapy would boost intracellular vitamin C concentrations and be considered safe."
doi: 10.3945/ajcn.113.068015
doi: 10.3945/ajcn.113.068015